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A B S T R A C T
BACKGROUND AND PURPOSE
We used L-[1–11C]leucine (LEU) positron emission tomography (PET) to measure amino
acid uptake in children with Sturge-Weber syndrome (SWS), and to relate amino acid
uptake measures with glucose metabolism.
METHODS
LEU and 2-deoxy-2[18F]fluoro-D-glucose (FDG) PET were performed in 7 children (age:
5 months-13 years) with unilateral SWS. Asymmetries of LEU uptake in the posterior
brain region, underlying the angioma and in frontal cortex, were measured and correlated
with glucose hypometabolism. Kinetic analysis of LEU uptake was performed in 4 patients.
RESULTS
Increased LEU standard uptake value (SUV, mean: 15.1%) was found in the angioma region
in 6 patients, and smaller increases in LEU SUV (11.5%) were seen in frontal cortex in
4 of the 6 patients, despite normal glucose metabolism in frontal regions. High LEU SUV
was due to both increased tracer transport (3/4 patients) and high protein synthesis
rates (2/4). FDG SUV asymmetries in the angioma region were inversely related to LEU
SUV asymmetries (r = –.83, P = .042).
CONCLUSIONS
Increased amino acid uptake in the angioma region and also in less affected frontal
regions may provide a marker of pathological mechanisms contributing to chronic brain
damage in children with SWS.
Introduction
Sturge-Weber syndrome (SWS) is a sporadic neurocutaneous
disorder characterized by a facial port wine stain and lep-
tomeningeal angiomatosis. The abnormal, tortuous veins on
the cortical surface lead to impaired cerebral blood flow, hy-
poxia, and chronic ischemia of the underlying brain tissue.1,2
The often progressive neurological complications include hemi-
paresis, visual field defects, seizures, and mental retardation.3
Leptomeningeal angiomas are generally considered to be devel-
opmental malformations, the results of a failed regression of the
primitive embryonal vascular plexus during the first trimester
of gestation.4 Recent studies, however, suggested that these an-
giomas may not be static lesions but, may undergo dynamic
proliferative changes.5,6 These studies have provided evidence
for increased expression of vascular cell proliferation markers
in the resected angioma and brain tissue. Histological studies
have shown neuronal degeneration, gliosis, and calcification
in the brain tissue adjacent to the angioma in SWS.5,7 These
degenerative changes are consistent with decreases in glucose
metabolism demonstrated by positron emission tomography
(PET).8
Increased cell proliferation has been studied in vivo using
PET to measure glucose metabolic rates, amino acid uptake (to
measure protein synthesis), and uptake of thymidine analogs
(to measure DNA synthesis); these approaches are commonly
used in the clinical setting to estimate proliferative activity of
malignancies.9,10 In brain tumors, amino acid uptake generally
provides a more accurate estimate of proliferative activity than
measures of glucose metabolism.11,12
Among several available amino acid PET tracers, 11C-
labeled leucine is very suitable to estimate tissue protein syn-
thesis rates because of its kinetic modeling.13,14 In this study,
we measured L-[1–11C]leucine (LEU) uptake in angioma re-
gions and in brain regions not directly affected by the an-
gioma in children with SWS who had unilateral, predomi-
nantly posterior, brain involvement associated with seizures.
We hypothesized that the posterior brain regions, affected di-
rectly by the angioma, would show increased uptake of LEU
on PET. To evaluate potential pathological correlates of abnor-
mal amino acid uptake in the angioma region, histopatholog-
ical features, including vascular proliferative activity and glial
markers, were assessed directly in a resected angioma of an
infant who underwent hemispherectomy following LEU PET.
In addition, we hypothesized that higher increases of LEU up-
take would be associated with more severe glucose metabolic
abnormalities, measured by 2-deoxy-2[18F]fluoro-D-glucose
(FDG) PET, due to more severe tissue damage underlying the
angioma.
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Materials and Methods
Subjects
Seven children (5 boys, age range: 5 months-13 years, median
age: 6 years at the time of LEU PET; Table 1) with the clinical
and radiological diagnosis of SWS who had unilateral hemi-
spheric involvement and history of seizures underwent MR
imaging as well as PET scanning using the tracers FDG and
LEU in the Children’s Hospital of Michigan, Detroit. These
children were selected from a series of 48 consecutive chil-
dren with SWS who were recruited between October 2004 and
August 2009 for a prospective neuroimaging research study,
including yearly clinical and imaging follow-ups, approved by
the Institutional Review Board at Wayne State University. All
selected patients (15% of the recruited patients) met the fol-
lowing inclusion criteria: (1) age below 14; (2) radiologic (mag-
netic resonance imaging [MRI] and FDG PET) evidence of
unilateral brain involvement; (3) history of seizures; (4) no ev-
idence of seizure(s) during PET; (5) parents‘ approval for a
second PET scan (LEU) in addition to FDG PET and MRI.
Five patients had right hemispheric, whereas two patients had
left hemispheric involvement. In one patient (patient no. 5),
leptomeningeal angioma could not be visualized onMRI; how-
ever, the presence of a right facial port wine stain as well as
right central transmedullary veins indicated right hemispheric
involvement. Some imaging studies were collected 1 year apart
from each other (see Table 1) as the patients participated in
a prospective, longitudinal study with yearly follow-ups (ex-
cept the infant who underwent hemispherectomy after initial
imaging). The MRI and FDG PET image data, which were the
closest to the LEU PET scan in time, were used for analysis
(Table 1). FDG and LEU PET scans were done at the same
time (1 day apart) in 5 patients and 1 year apart in the remain-
ing two (patients no. 4 and no. 7). These latter patients were 5
and 11.8 years old at the time of the first scan; thus, both of them
were older than 3 years when major metabolic progression had
been observed.15 Written informed consent was obtained from
the parents or legal guardians.
FDG PET Data Acquisition
All PET scans were performed using a CTI/Siemens
EXACT/HR scanner (Siemens, Knoxville, TN). This scanner
has a 15 cm field of view and generates 47 image planes with a
slice thickness of 3.125 mm. The FDG PET scanning protocol
has been described in detail previously.16 The reconstructed in-
plane resolution is 5.5 mm (±.35) full width at half maximum
and 6.0 mm (±.49) in the axial direction. Initially, a venous line
was established to inject FDG (.143 mCi/kg). After 40 minutes
of FDG uptake, a static 20-minute emission scan of the brain
was acquired in 3-dimensional (3D) mode. Calculated attenua-
tion correction was applied to the brain images using automated
threshold fits to the sinogram data. All FDG PET scans were
performed in the interictal state as indicated by EEG monitor-
ing performed during the FDG uptake period.
LEU PET Data Acquisition
The tracer L-[11C]-leucine was produced at Children’s Hospi-
tal of Michigan using a synthesis module designed and built in T
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house.17 Details of the imaging procedure have been described
previously.14 Four of the 7 patients had blood input data ob-
tained during the PET study for more detailed quantification.
The PET sequence began with a transmission scan of the chest.
Subsequently, the tracer L-[1–11C]-leucine (.1 mCi/kg) was in-
jected, and a 20-minute dynamic PET scan of the heart was
performed (sequence: 12 × 10 s, 3 × 60 s, 3 × 300 s) in order
to obtain the left ventricular (LV) input function. Continua-
tion of the input function was then accomplished by combining
the time-activity curve derived from a small region-of-interest
(ROI) in the center of the LV with venous blood samples ob-
tained at later times. Subsequently, beginning at 25 minutes
following tracer injection, seven 5-minute scans of the brain
were performed in 3D mode followed by a 15-minute transmis-
sion scan of the brain. Measured attenuation, scatter, and decay
correction were applied to all PET images. Scalp EEG was not
monitored during the LEU uptake period.
MRI Data Acquisition
All MRI studies were carried out on a Sonata 1.5 T MRI scan-
ner (Siemens, Erlangen, Germany) using a standard head coil.
For the purpose of the present study, only the postgadolinium
T1-weighted images (T1-Gad) were used (as a reference for
coregistration of PET images). The acquisition parameters of
this sequence were as follows: TR/TE:20/5.6 ms; flip angle:
25◦; voxel size: 1 × .5 × 2 mm3.
Sedation during Imaging Studies
Children aged <2 years were sedated with chloral hydrate (50-
100mg/kg bymouth), and children aged 2-8 years were sedated
with nembutal (3 mg/kg), followed by fentanyl (1 μg/kg), as
necessary. All sedated subjects were continuously monitored
by pediatric nurses, and physiological parameters (heart rate,
pulse oximetry, respiration) were measured during the studies.
ROI Definition
FDG PET images as well as summed and individual frames
of the LEU PET images were initially rigid-body coregistered
to each patient‘s T1-Gad MR images using a 3D registration
technique (VINCI 2.50).18 Subsequently, ROIs encompassing
the angioma region (including the angioma and the underly-
ing cortex; these structures were not delimited separately, since
they cannot be distinguished on PET images due to their close
proximity) as well as mirror regions in the contralateral hemi-
sphere were defined on the gadolinium-enhanced MRI images
using ROI Editor 1.4.1 (www.mristudio.org). All these regions
were located mainly in the posterior (temporal, parietal, occip-
ital) cortex. In patient no. 5, with no leptomeningeal angioma
visualized on MRI, similar posterior cortex was included in
this ROI. In addition, ROIs were drawn on at least three im-
age planes in apparently spared (no atrophy and angioma) or
less affected (mild hypometabolism in some cases; see Table 1)
frontal cortical regions ipsilateral to the angioma as well as in
contralateral homotopic regions. All ROIs were then superim-
posed on the coregistered FDG and LEU PET images including
the dynamic LEU image sequences, in cases where blood input
data were available. In subjects, who had MRI and PET scans
acquired 1 year apart, small manual adjustments of the ROIs
had to be carried out to adjust for interim changes in brain size.
Semi-Quantitative Analysis of FDG and LEU Uptake
Standardized uptake values (SUVs) for FDG and LEU uptake
were calculated for all regions by dividing the average radioac-
tivity concentration obtained from each region by the injected
FDG and LEU dose per total body weight, respectively. Sub-
sequently, asymmetry indices (AIs) for SUVs were calculated
as follows: AI (%) = 200 × [(I – C)/(I + C)], where I repre-
sents ipsilateral, C represents contralateral values as compared
to the side of the lesion. For FDG, AI values above 10% were
considered to be abnormal.15,16 For LEU, normal control asym-
metries were calculated using LEU PET images of five healthy
adults (all males, mean age: 39 years), where absolute values of
right-left SUVAIs were calculated for both posterior and frontal
regions, separately, and AI values above the normal mean ± 3
standard deviations (SDs) were considered to be abnormal in
the patients. We used the conservative 3 SDs because of the
unknown age-related differences in normal AIs of cortical LEU
uptake.
Quantitative Analysis of Protein Synthesis
To study mechanisms of LEU uptake abnormalities, unidirec-
tional uptake rate constant (K-complex) and volume of distri-
bution (VD) were derived from the Patlak graphical analysis19
in 4 cases where blood input data were available. Details of
this approach have been described previously.14 Asymmetries
(AIs) for K-complex and VD were calculated similar to those
for SUVs. Again, AI values above the normal mean ± 3 SDs,
derived from the normal controls, were considered to be abnor-
mal. Absolute SUV, K-complex, and VD values of the patients
were not compared to those of the healthy adults due to po-
tential developmental differences in cerebral protein synthesis
rates.20
Statistical Analysis
Hemispheric asymmetries in the angioma and frontal regions
were compared using Wilcoxon‘s signed-rank test. Association
between glucose metabolic and LEU uptake asymmetries was
tested using Spearman’s rank correlation. P < .05 was consid-
ered statistically significant.
Histological assessment of resected tissue samples
Resected specimens were available from one patient, an infant
who underwent hemispherectomy at 6 months of age. In ad-
dition to standard histological processing of the resected brain
and angioma tissues (including hematoxyilin-eosin, cresyl vi-
olet, Masson trichrome, glial fibrillary acidic protein [GFAP],
and synaptophysin immunostaining, Luxol fast-blue/periodic-
acid Schiff), angioma specimens were also immunostained us-
ing Ki-67 antibody (clone K-2, Ventana), colabeled with the
endothelial marker CD31 (JC70A, Ventana, Tucson, AZ, USA)
to demonstrate proliferative activity in the endothelial cells of
the angioma.6,21 Furthermore, the expression of vascular en-
dothelial growth factor-A (VEGF-A) was also assessed (using
mouse antihuman monoclonal antibodies; sc-7269, Santa Cruz
Inc., Santa Cruz, CA, USA) in the resected angioma specimen.
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Fig 1. Representative co-registered T1 postgadolinium MRI (A), FDG PET (B), and L-[1–11C]leucine (LEU) PET (C) images of a 6-year-old
girl (patient no. 4) with left hemispheric angioma in the temporo-parieto-occipital region. Solid arrows indicate the angioma region, which was
hypometabolic (AI = –61%) but showed abnormally increased LEU uptake (AI = 12%). Although the MRI showed deep transmedullary veins
in the frontal lobe, the angioma did not extend to the frontal cortex. However, this region was also mildly hypometabolic (dashed arrow; AI =
9%) and showed moderately increased LEU uptake (SUV AI = 9%) compared to the contralateral homotopic area.
Immuno-histochemistry results of resected brain tissues of 7
(non-SWS) patients (age range: 4 months-7 years), who under-
went epilepsy surgery, are also presented for comparison.
Results
FDG and LEU Uptake Asymmetries
LEU SUV asymmetries in the angioma and frontal regions
exceeded the calculated normal cutoff values (3.8% for the an-
gioma region and 3.3% for frontal cortex) in 6 and 4 cases,
respectively (mean AIs for these abnormal cases: angioma—
15.1%, frontal—11.5%; see Fig 1). FDG SUV asymmetries were
abnormal (>10%) in 5 patients in the angioma region (mean
AI: 55.7%) and in none of the patients in the frontal region.
Glucose metabolic asymmetries of the angioma region were
significantly higher than those of the frontal regions (–39.7%
vs. –2.3%; P = .028). However, LEU uptake asymmetries of
the angioma region were only slightly higher than those of the
frontal regions (12.7 vs. 6.6%; P = .09).
Quantification of LEU Uptake
Four patients had blood input data to estimate regional pro-
tein synthesis rates. K-complex asymmetries exceeded the nor-
mal AI limit (angioma region: 4.8%; frontal: 4.4%) in the 2
youngest children (ages: 2.4 and 2.9 years) where quantifica-
tion was available in the angioma region (increases; AI: 8.7%
and 6.5%, respectively) and in none of the cases in the frontal
cortex (Table 1). VD asymmetry was above the normal AI limit
(angioma region: 28%, frontal: 30%) in the angioma region in
3 patients and in the frontal region in 1 child, always with higher
values ipsilateral to the angioma.
Association between Glucose Hypometabolism
and LEU Uptake
We found a significant negative correlation between FDG SUV
asymmetries and LEUSUVasymmetries for the 6 patients older
Fig 2. Relationship between glucose metabolic (FDG) versus
L-[1–11C]leucine (LEU) uptake asymmetries (AIs) in the angioma
region. Black circles represent datapoints from the six older (above
the age of 2 years) patients with chronic disease. A correlation for
these patients’ data indicates that higher LEU uptake ipsilateral to the
angioma is associated with more severe glucose hypometabolism
(r = –.83, P = .042). In addition, the cross indicates the data of
an infant with recent onset seizures. This case was not included in
the correlation since glucose uptake is not an appropriate measure
of cortical damage in the initial stage of the disease when potential
transition of cortical hypermetabolism to hypometabolism occurs.
than 2 years of age in the angioma regions (r = –.83, P = .042,
see Fig 2) and a trend for the same association in the frontal
regions (r = –.77; P = .07), indicating that higher LEU up-
take was associated with more severe hypometabolism. For this
analysis, we excluded patient no. 1, a 5-month-old infant. In
this age group, patients with SWS often show increased glu-
cose metabolism and blood flow, followed by a transition from
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Fig 3. Immunostaining for the proliferation marker Ki-67 (costained with endothelial marker CD31; A) and VEGF-A (C) in resected angioma
tissue as well as cortex (B and D) of an infant (patient no. 1) who underwent hemispherectomy at 6 months of age. These representative
images show positive Ki-67 labeling (brown stain) in numerous endothelial nuclei of the leptomeningeal angioma (one of the Ki-67 positive
nuclei is shown by a red arrow) as well as intense VEGF-A staining (brown) in leptomeningeal vessels. No Ki-67 staining was seen in the cortex
but numerous cells showed VEGF-A expression. The representative images at the bottom show no endothelial Ki-67 expression (E) and no
neuronal staining for VEGF (F) in tissue samples of one of the control subjects (a 4-year-old patient with intractable temporal lobe epilepsy).
increased to decreased metabolism and blood flow.22 This pa-
tient’s data point may be an outlier (see point denoted by X in
Fig 2) in this comparison for this reason.
Histopathological Assessment
The surgical specimen from the infant who underwent epilepsy
surgery showed marked leptomeningeal vascularity, cortical
malformation (polymicrogyria and heterotopias), neuronal loss,
gliosis (positive GFAP immunostaining), and prominent calci-
fication. Positive Ki-67 labeling was seen in the nuclei of en-
dothelial cells (Fig 3A) but not in cortical cells (Fig 3B). The cal-
culated proliferative index (proportion of labeled endothelial
cells) was between 5% and10%. In comparison, no endothelial
Ki-67 staining was seen in control tissues (Fig 3E). In addition,
we also found strong VEGF-A expression in endothelial cells
of the angioma as well as in cortical neurons (Figs 3C, D). Pe-
diatric epilepsy control tissues showed no, or weak, staining for
VEGF (Fig 3F).
Discussion
The main finding of this study is the increased LEU SUV of
the angioma region and in the frontal lobe in some cases in
children with SWS. Based on the available data with quantifi-
cation, these increases are driven by elevated VD of labeled
leucine indicating elevated LEU transport in 3 of the 4 cases
and also by increased protein synthesis rates reflected by the
K-complex in 2 of the 4 cases. These results increase our under-
standing of pathological changes occurring in brain underlying
the angioma and beyond in frontal cortical regions showing rel-
atively normal glucose metabolism. Elevations in amino acid
transport and protein synthesis may be related to endothelial
and glial proliferation, which were observed in the one case in
which brain tissue was available for pathological studies. Al-
tered blood-brain barrier (BBB) is also a probable mechanism
for increased amino acid uptake near the angioma. Further
studies are needed to understand these mechanisms more fully.
This is a preliminary study with a limited number of subjects.
Additional major limitations include that FDG and LEU PET
images were acquired 1 year apart from each other in some
cases. Furthermore, detailed kinetic analysis could be carried
out in only a subset of the study group. Importantly, the an-
gioma and the underlying cortex could not be distinguished on
the PET images since partial volume effects preclude the reli-
able separate analysis of these structures. Therefore, our results
most likely represent a summed effect of abnormal amino acid
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transport and protein synthesis in these structures, at least in
the angioma-affected regions. In addition, changes in glucose
metabolism during development in the region of the angioma
complicate our analysis. In SWS, FDG PET often detects pro-
found cortical hypometabolism of the affected hemisphere, pre-
dominantly under the angioma but frequently extending well
beyond the apparent structural abnormalities seen onMRI.16,22
We found a significant inverse association between the severity
of hypometabolism and the increase in LEU uptake in chil-
dren above 2 years of age. In the only infant (a 5-month-old
boy), LEU uptake showed the highest AI value, while FDG AI
was relatively moderate. However, this latter may not reflect
the true degree of tissue damage in this young age, as infants
with SWS are known to show transient hypermetabolism,22
followed by a transition from hyper- to hypometabolism in the
affected brain regions. Therefore, it is possible that in this infant,
FDG PET underestimated the severity of cortical involvement.
In the 6 older children, higher LEU uptake associated with
lower glucose metabolism suggests that the degree of amino
acid transport and protein synthesis (related to BBB damage,
glial, or vascular proliferation) is associated with tissue damage
as reflected by low glucose metabolism.
Recent studies have demonstrated that intracranial vascular
malformations in SWS are not static lesions but may undergo
dynamic remodeling.5 Enhanced endothelial cell turnover as
well as increased expression of key angiogenetic factors, such
as VEGF and its receptor, provided evidence for ongoing an-
giogenesis and suggested the progressive nature of angiomas.5,6
In addition to the leptomeningeal angioma, the structure and
neural regulation of cortical vessels are also affected in this dis-
order.23,24 Whether these vascular changes contribute to clini-
cal disease progression remains to be clarified.
In our study, the increased LEU uptake in the angioma
region was mainly driven by the increase in the VD of the
tracer, suggesting increased amino acid transport. The marked
increase of LEU VD may be due to the retention of the amino
acid by increased vascular beds, disruption of the BBB, in-
creased capillary permeability, and/or increased expression of
the large amino acid transporter (LAT1).23,25 Contrast enhance-
ment of the leptomeningeal angioma onMRI suggests BBB dis-
ruption, which itself can lead to increased amino-acid uptake.26
Increased uptake of two other amino-acid tracers (ie, 11C-
methionine and α-[11C]methyl-L-tryptophan, where increased
VD, but not high K-complex, was associated with contrast en-
hancement) has been demonstrated in brain tumors and other
pathological conditions associated with BBB breakdown.27,28
In contrast, FDG uptake is not sensitive to BBB disruption,29,30
thus, glucose metabolic rates on PET may remain low even
in the case of impaired BBB. Accumulation of 11C-methionine
(which, similar to leucine, is a substrate of LAT1) on PETwas re-
ported in the angioma region of an adult with SWS,25 but quan-
tification of methionine uptake has not been performed. The
mechanism of the increase in the K-complex macroparameter
also remains to be determined. Based on a study from Comati
et al. and our previous work demonstrating proliferative activ-
ity and angiogenesis in the vascular malformations,5,6 increased
protein synthesis may be expected in the angioma due to ac-
tive remodeling. This is supported by immuno-histochemistry
findings in our youngest patient, showing endothelial Ki-67 pro-
liferative index of 5-10%, similar to what could be expected in
low-grade tumors.31 Importantly, other factors, such as cortical
glial proliferation or increased expression and deposition of ex-
tracellular matrix proteins such as fibronectin4 could also con-
tribute to high protein synthesis in the angioma region. In addi-
tion, cortical malformations (also seen in our infant) have been
reported in patients with SWS32 and these epilepsy-associated
developmental abnormalities can show increased amino acid
uptake.33 Detection of such malformations by imaging could be
of high clinical importance in SWS as these lesions are highly
epileptogenic and should be considered when partial resec-
tion is planned in children with SWS and intractable epilepsy.
Although mechanisms of increased LEU uptake are currently
speculative and warrant further studies, our imaging findings
suggest that increased LEU uptake on PET may be a useful
marker of underlying pathology not only in angioma-affected
regions but also in frontal cortex even when it shows no ap-
parent abnormalities on conventional imaging in children with
SWS.
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